UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 229

Sortiert nach

Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2020-02, Vol.55 (2), p.409-418

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study

Stem cell research & therapy, 2023-04, Vol.14 (1), p.95-95, Article 95

2023

Link zum Volltext

Verfügbarkeit prüfen

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder

EJHaem, 2023-08, Vol.4 (3), p.848-851

2023

Link zum Volltext

Verfügbarkeit prüfen

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2020-01, Vol.55 (1), p.12-24

2020

Link zum Volltext

Verfügbarkeit prüfen

Specificity of HLA monoclonal antibodies and their use to determine HLA expression on lymphocytes and peripheral blood stem cells

HLA, 2024-01, Vol.103 (1), p.e15192-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis

Blood, 2022-11, Vol.140 (20), p.2101-2112

2022

Link zum Volltext

Verfügbarkeit prüfen

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes

Blood cancer journal (New York), 2021-07, Vol.11 (7), p.125-125, Article 125

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience

Cancer medicine (Malden, MA), 2023-05, Vol.12 (10), p.11248-11253

2023

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib

Bone marrow transplantation (Basingstoke), 2022-05, Vol.57 (5), p.830-833

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients

Transplantation and cellular therapy, 2021-11, Vol.27 (11), p.938.e1-938.e6

2021

Link zum Volltext

Verfügbarkeit prüfen

Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Bone marrow transplantation (Basingstoke), 2022-01, Vol.57 (1), p.134-136

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells

Clinical and translational medicine, 2021-10, Vol.11 (10), p.e610-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Total marrow irradiation

Frontiers in oncology, 2023-07, Vol.13, p.1240530-1240530

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2021-10, Vol.56 (10), p.2464-2470

2021

Link zum Volltext

Verfügbarkeit prüfen

Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens

Bone marrow transplantation (Basingstoke), 2022-02, Vol.57 (2), p.232-242

2022

Link zum Volltext

Verfügbarkeit prüfen

Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23 (9), p.e268-e276

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of allosensitized patients receiving allogeneic transplantation

Blood advances, 2021-10, Vol.5 (20), p.4031-4043

2021

Link zum Volltext

Verfügbarkeit prüfen

New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT)

Hematology, 2022-12, Vol.2022 (1), p.74

2022

Link zum Volltext

Verfügbarkeit prüfen

Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.229.e1-229.e11

2024

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage Therapies

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.255.e1-255.e9

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Englisch
(229)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(90)
Science & Technology
(90)
Hematology
(76)
Humans
(72)
Transplantation
(53)
Immunology
(40)
Adult
(29)
Middle Aged
(28)
Retrospective Studies
(28)
Oncology
(26)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(25)
Hematopoietic Stem Cell Transplantation
(21)
Male
(20)
Female
(19)
Graft Vs Host Disease - Etiology
(18)
Hematopoietic Stem Cells
(18)
Stem Cell Transplantation
(18)
Graft Vs Host Disease - Prevention & Control
(16)
Young Adult
(16)
Aged
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Protective effect of HLA-DPB1 mismatch remains valid in reduced-intensity conditioning unrelated donor hematopoietic cell transplantation

The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder

Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

Specificity of HLA monoclonal antibodies and their use to determine HLA expression on lymphocytes and peripheral blood stem cells

The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience

Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients

Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells

Editorial: Total marrow irradiation

Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration

Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL

Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma

Treatment of allosensitized patients receiving allogeneic transplantation

Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status

New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT)

Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage Therapies

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Suchergebnisse filtern